Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

See Locations Near You

Summary

The purpose of this study is to determine the response rate to treatment with oxaliplatin and Navelbine in patients with previously treated NSCLC. Oxaliplatin and Navelbine have not been clinically evaluated yet. However, Navelbine has been safely administered with other platinum compounds.

View Full Description

Full Description

This is a non-randomized trial for patients with previously treated Non-small cell lung cancer. Each patient will receive 6 cycles of chemotherapy consisting of Oxaliplatin and Navelbine. Oxaliplatin is given intravenously every 21 days and Navelbine is administered Intravenously on day 1 and day 8 every 21 days.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Locally advanced or metastatic non-small cell lung cancer that has recurred, progressed, or failed to respond to previous systemic chemo.
Measurable disease
Good performance status (ECOG 0,1 or 2)

Exclusion Criteria:

Previously treated with Oxaliplatin or Navelbine
Symptomatic CNS metastases

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

40

Study ID:

NCT00238849

Recruitment Status:

Unknown status

Sponsor:

Integrated Community Oncology Network

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Integrated Community Oncology Network
Jacksonville Florida, 32256, United States More Info
Diane Edwards, RN,OCN,CCRP
Contact
904-363-7471
[email protected]
Gloria Perez, RN,BSN,OCN
Contact
904-739-7779
[email protected]
Integrated Community Oncology Network
Orange Park Florida, 32073, United States More Info
Carla Malott, RN
Contact
904-272-3139
[email protected]
Joan Ollie, BSN, RN
Contact
904-272-3139
[email protected]
Thomas A Marsland, MD
Principal Investigator
Linda S Sylvester, MD
Sub-Investigator
Kenneth Goldstein, MD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

40

Study ID:

NCT00238849

Recruitment Status:

Unknown status

Sponsor:


Integrated Community Oncology Network

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider